Answers are grounded in this paper and cite their sources.
Susceptibility breakpoints are crucial for prudent use of antimicrobials. This study has developed the first susceptibility breakpoint (MIC ≤ 0.25 μg/ml) for enrofloxacin against swine Salmonella spp. based on wild-type cutoff (COWT) and pharmacokinetic-pharmacodynamic (PK-PD) cutoff (COPD) values, consequently providing a criterion for susceptibility testing and clinical usage of enrofloxacin.
No takes yet. Share an insight, caveat, or question.
Hao et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: